This chapter provides a comprehensive analysis of the global medical device market through a multidimensional lens, emphasizing stakeholder interdependencies, market structures, and macroeconomic trends. Initial mapping the ecosystem of key stakeholders being manufacturers, regulators, payers, healthcare providers, patients, and global institutions, highlights their evolving roles in innovation, regulation, and adoption. The chapter then explores the strategic weight of these stakeholders, varying significantly by region and shaped by regulatory maturity, industrial policy, and patient advocacy. A dedicated section examines the patient’s shifting role from passive recipient to active co-creator and data contributor, reshaping device design and evaluation. Commercial segmentation is analyzed through B2B, B2C, and B2G models, with insights into how distribution, purchasing behavior, and policy affect regional strategies. A detailed PEST analysis outlines political, economic, social, and technological forces influencing global operations. The chapter also presents a macroeconomic perspective and explores regional differences in per capita spending, infrastructure maturity, and investment capacity between high-income regions and emerging markets. Market drivers, including aging populations, chronic disease, digital health, and rising health expenditures, are contrasted with structural challenges, including regulatory complexity, pricing pressure, and workforce shortages. The chapter concludes with a SWOT analysis, distilling strengths, weaknesses, opportunities, and threats shaping the global industry.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Medical Devices: Market Environment & Stakeholder Analysis

  • Giancarlo Prestinoni

摘要

This chapter provides a comprehensive analysis of the global medical device market through a multidimensional lens, emphasizing stakeholder interdependencies, market structures, and macroeconomic trends. Initial mapping the ecosystem of key stakeholders being manufacturers, regulators, payers, healthcare providers, patients, and global institutions, highlights their evolving roles in innovation, regulation, and adoption. The chapter then explores the strategic weight of these stakeholders, varying significantly by region and shaped by regulatory maturity, industrial policy, and patient advocacy. A dedicated section examines the patient’s shifting role from passive recipient to active co-creator and data contributor, reshaping device design and evaluation. Commercial segmentation is analyzed through B2B, B2C, and B2G models, with insights into how distribution, purchasing behavior, and policy affect regional strategies. A detailed PEST analysis outlines political, economic, social, and technological forces influencing global operations. The chapter also presents a macroeconomic perspective and explores regional differences in per capita spending, infrastructure maturity, and investment capacity between high-income regions and emerging markets. Market drivers, including aging populations, chronic disease, digital health, and rising health expenditures, are contrasted with structural challenges, including regulatory complexity, pricing pressure, and workforce shortages. The chapter concludes with a SWOT analysis, distilling strengths, weaknesses, opportunities, and threats shaping the global industry.